Is UNCY up or down today?
UNCY is down 0.38% today, last at 5.29. This stock moved -0.38% versus the prior close.
UNCY · UNCY
UNCY (UNCY) is trading at 5.29, down 0.38% on the session. UNCY sits at the 31% mark of its 52-week range, carries a 14-day RSI of 49, and trades above its 50-day average. Over the past month it is down 1.86%.
Leading the coverage: “Unicycive faces class action over undisclosed F... - Pluang” (Google News Company, 4d ago). UNCY is +2.52% since story.
UNCY trades on a trailing P/E of 17.6 and is running 0.80% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
UNCY is down 0.38% today, last at 5.29. This stock moved -0.38% versus the prior close.
Leading the coverage: “Unicycive faces class action over undisclosed F... - Pluang” (Google News Company, 4d ago). UNCY is +2.52% since story. Dominant story: UNCY Stock Crashed 45% Today – Why Did FDA Reject Its Kidney Disease NDA For A Second Time? (2 sources, neutral) RSI is 49 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
UNCY Stock Crashed 45% Today – Why Did FDA Reject Its Kidney Disease NDA For A Second Time? - Stocktwits
UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval - Stocktwits
UNCY INVESTOR REMINDER: Unicycive Therapeutics, Inc. Investors Ha - The National Law Review
UNCY Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm to Learn About Their Legal Rights - FinancialContent